T 1679/22 (shifting an isoelectric profile / ALEXION PHARMACEUTICALS) of 15.10.2024

European Case Law Identifier: ECLI:EP:BA:2024:T167922.20241015
Date of decision: 15 October 2024
Case number: T 1679/22
Application number: 15795064.3
IPC class: C12N 15/09
C12N 5/00
Language of proceedings: EN
Distribution: D
Download and more information:
Decision text in EN (PDF, 260 KB)
Documentation of the appeal procedure can be found in the Register
Bibliographic information is available in: EN
Versions: Unpublished
Title of application: METHODS OF SHIFTING AN ISOELECTRIC PROFILE OF A PROTEIN PRODUCT AND USES THEREOF
Applicant name: Alexion Pharmaceuticals, Inc.
Opponent name: Stolmár, Matthias
Board: 3.3.08
Headnote: -
Relevant legal provisions:
European Patent Convention 1973 Art 113(1)
European Patent Convention 1973 Art 116(1)
Keywords: Basis of decision - text or agreement to text withdrawn by patent proprietor
Basis of decision - patent revoked
Catchwords:

-

Cited decisions:
T 0073/84
T 0186/84
T 1182/17
T 0774/20
T 1995/21
Citing decisions:
-

Summary of Facts and Submissions

1. The appeal lodged by the opponent (appellant) lies from the decision of the opposition division rejecting the opposition against European patent No. 3 207 132 granted on European patent application No. 15795064.3, which was filed as an international application under the PCT and published as WO 2016/061065.

2. The appellant requested inter alia that the decision under appeal be set aside and amended such that the patent be revoked.

3. The respondent (patent proprietor) requested inter alia that the appeal be dismissed (main request), or alternatively, that the patent be maintained with the set of claims of one of auxiliary requests 1 to 32.

4. The board summoned the parties to oral proceedings in accordance with their requests and subsequently issued a communication pursuant to Article 15(1) RPBA.

5. With a submission dated 8 October 2024 the patent proprietor declared the following:

"The patent proprietor withdraws its approval of the granted text of this patent, and will not be submitting an amended text.

We understand that this will result in revocation of the patent and termination of the opposition proceedings against the patent."

6. In view of this declaration the oral proceedings were cancelled.

Reasons for the Decision

7. Pursuant to Article 113(2) EPC, the EPO will examine, and decide upon, the European patent only in the text submitted to it, or agreed by the applicant or patent proprietor.

8. Since the text of the patent is at the disposition of the patent proprietor, their patent cannot be maintained against their will. In the present case the patent proprietor withdrew their approval of the text of the patent as granted. Further, by declaring that they will not be submitting any amended text of the patent and requesting that the patent be revoked, they also unequivocally declared that all pending auxiliary requests were at the same time withdrawn. Consequently, there is no longer any text of the patent in the proceedings which the board can consider for compliance with the requirements of the EPC.

9. In these circumstances, as there is no approved text, the patent is to be revoked without assessing issues relating to patentability (see e.g. decisions T 73/84 (OJ EPO 1985, 241), T 186/84, (OJ EPO 1986, 79); decisions T 1182/17, T 774/20, T 1995/21 and Case Law of the Boards of Appeal of the European Patent Office, 10th edition 2022, sections III.B.3.3 and IV.D.2). There is no reason to deviate from this consistent approach of the Boards of Appeal, with the consequence that the patent is to be revoked.

10. Revocation of the patent complies with the request of the appellant. The present decision can therefore be taken without holding oral proceedings (Article 116(1) EPC and Article 12(8) RPBA 2020).

Order

For these reasons it is decided that:

1. The decision under appeal is set aside.

2. The patent is revoked.

Quick Navigation